Department of Radiology, Eulji University Hospital, 1306 Dunsan-dong, Seo-gu, Daejeon, South Korea.
Eur J Radiol. 2009 Nov;72(2):274-7. doi: 10.1016/j.ejrad.2008.07.026. Epub 2008 Sep 7.
To describe the magnetic resonance (MR) imaging features of six cases of pathologically proven fibrosing inflammatory pseudotumor involving the nasopharynx, and to compare the MR signal intensities of the lesions with histopathologic findings.
We reviewed the MR finding of six patients with pathologically proved fibrosing inflammatory pseudotumor at the nasopharyngeal wall with respect to the following points: extent, margins, signal intensity and enhancement degree of the lesion; cervical lymphadenopathy and response to steroid therapy. MR findings were correlated with histopathologic findings.
All lesions showed ill-defined margins and looked less-likely contour bulging features. The signal intensity of the lesions was hypointense or slightly heterogeneous relative to brain cortex on both T1- and T2-weighted images, and enhancement was weakly homogeneous in all cases. There was no demonstrable cervical lymphadenopathy in all cases. After steroid therapy, the lesions showed decreased extent and weaker enhancement in three patients. Histopathologic findings showed high degree of polymorphous inflammatory cellular infiltration with underlying significant reactive fibrosis.
Fibrotic inflammatory pseudotumors involving nasopharynx are very rare, and can mimic malignancy. MR imaging showed ill-defined margins, hypointensity or slightly heterogenous signal intensity on T2-weighted image and weak enhancement. There was no significant cervical lymphadenopathy.
描述 6 例经病理证实的累及鼻咽部的纤维炎性假瘤的磁共振成像(MR)特征,并将病变的 MR 信号强度与组织病理学发现进行比较。
我们回顾了 6 例经病理证实的纤维炎性假瘤患者的 MR 表现,主要涉及病变的范围、边缘、信号强度和强化程度;颈部淋巴结病和对类固醇治疗的反应。MR 发现与组织病理学发现相关。
所有病变均表现为边界不清,不太可能有轮廓膨出的特征。病变的信号强度在 T1 和 T2 加权图像上相对于脑皮质均为低信号或轻度不均匀,所有病例的强化均为弱均匀。所有病例均无明显的颈部淋巴结病。在类固醇治疗后,3 例患者的病变范围减小,强化程度减弱。组织病理学发现表现为高度多形性炎症细胞浸润,伴有明显的反应性纤维化。
累及鼻咽部的纤维性炎性假瘤非常罕见,可模拟恶性肿瘤。MR 成像显示边界不清,T2 加权图像上呈低信号或轻度不均匀信号强度,强化程度较弱。无明显的颈部淋巴结病。